98354380

Information

• Trademark
• 98354380

• Source

• Serial Number

  98354380

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 12, 2024
  a year ago

• Transaction Date

  March 04, 2025
  22 days ago

• Status Date

  March 04, 2025
  22 days ago

• Published for Opposition Date

  March 04, 2025
  22 days ago

• Location Date

  February 13, 2025
  a month ago

• Status Code

  686

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CHUO, EMILY

• Attorney Docket Number

  NEUB 2401109

  Attorney Name

  Allison Strickland Ricketts

  Law Office Assigned Location Code

  L10

• Owners

  • Neurocrine Biosciences, Inc.

Case File Statements

• DM0000: The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear left to right in a gradient of color from purple to orange to yellow.
• GS0051: pharmaceutical preparations for human use for the treatment of adrenal insufficiency; pharmaceutical preparations for human use for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
• CC0000: The color(s) purple, orange, and yellow is/are claimed as a feature of the mark.
• GS0441: Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
• GS0421: providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results

Case File Event Statements

• 1/12/2024 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 5/5/2024 - 10 months ago

  4 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/5/2024 - 10 months ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/5/2024 - 10 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/15/2024 - 10 months ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 5/30/2024 - 10 months ago

  6 - PRIORITY ACTION WRITTEN Type: CPRA

• 5/30/2024 - 10 months ago

  7 - PRIORITY ACTION E-MAILED Type: GPRA

• 5/30/2024 - 10 months ago

  8 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 7/31/2024 - 7 months ago

  9 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 8/27/2024 - 7 months ago

  14 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 7/31/2024 - 7 months ago

  10 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 8/15/2024 - 7 months ago

  12 - PRIORITY ACTION E-MAILED Type: GPRA

• 8/15/2024 - 7 months ago

  13 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 8/15/2024 - 7 months ago

  11 - PRIORITY ACTION WRITTEN Type: CPRA

• 8/27/2024 - 7 months ago

  15 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 2/7/2025 - a month ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/7/2025 - a month ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/7/2025 - a month ago

  16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/12/2025 - a month ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/26/2025 - 28 days ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/4/2025 - 22 days ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/4/2025 - 22 days ago

  22 - PUBLISHED FOR OPPOSITION Type: PUBO